Fibromyalgia and the Nervous System: What Is Happening
Fibromyalgia is best understood as a condition in which the nervous system turns the volume on pain up too high. Researchers describe it as a disorder of pain processing, where the brain and spinal cord amplify signals that other people would barely notice. That explains why the pain is widespread, why it comes with fatigue, unrefreshing sleep and brain fog, and why scans and X-rays of your joints so often look normal. It is a real, measurable biological process, and it is also why a DNA-based blood test such as the FM1® Test was built to look for immune-system changes tied to fibromyalgia, so that your symptoms can be backed by objective evidence.
TL;DR
- Fibromyalgia involves abnormal pain processing in the central nervous system: both the pathways that carry pain upward and the ones that dampen it work differently than usual.
- Brain imaging and pain-threshold studies show measurable differences, which is why the pain is physical and not imagined.
- The same changes help explain fatigue, poor sleep and “fibro fog”, and the peripheral and autonomic nerves may play a part too.
- Many people wait years for an answer, and an estimated 75% of people with fibromyalgia remain undiagnosed.
- Our FM1 Test uses a simple blood draw, with results available within about a week.
Table of Contents
- How fibromyalgia changes the way your nervous system handles pain
- What the research actually shows
- Why fatigue, poor sleep and brain fog come with the pain
- Beyond the brain: peripheral and autonomic nerves
- What this means for getting a diagnosis
- How the FM1 Test fits in
- Our perspective
- FAQ
- Sources
How fibromyalgia changes the way your nervous system handles pain
Your nervous system works like a signal network. Nerves in your body send messages up the spinal cord to the brain (the ascending pathways). The brain then sends messages back down to turn the signal up or down (the descending pathways). In most people, the descending system acts like a brake that filters out minor signals.
According to a consensus paper by pain specialists Clauw, Arnold and McCarberg, fibromyalgia is a disorder in which both ascending and descending pathways operate abnormally. The result is central amplification of pain, which the authors describe as the volume control for pain being set abnormally high. Two things happen together: central neurons become more excitable, and the body’s natural pain-inhibiting mechanisms weaken.
Two terms are worth knowing, because your doctor may use them:
- Allodynia is pain from something that should not hurt, such as a light touch or the pressure of clothing.
- Hyperalgesia is stronger pain than expected from something that normally hurts a little.
A 2026 review describes this as central sensitization: nerve cells in the brain and spinal cord respond more strongly than they should. The same review notes that the hypersensitivity in fibromyalgia spreads across the body instead of staying in specific tender spots, and that it involves a network of brain regions, including the insula, the anterior cingulate cortex, the thalamus and the prefrontal cortex. It also cautions that central sensitization is not the whole explanation, which is why researchers are still mapping the full picture.
The chemistry behind the volume knob
The Clauw paper also reports chemical differences in the fluid surrounding the brain and spinal cord. Levels of substances that promote pain signaling, including substance P, nerve growth factor, BDNF and glutamate, are higher. Breakdown products of serotonin, norepinephrine and dopamine, the chemicals that help calm pain signaling, are lower. You do not need to memorize the names. The point is that the imbalance runs in one direction: more “go” signals, fewer “stop” signals.
A 2023 clinical review in American Family Physician adds that functional brain imaging suggests an imbalance between excitatory and inhibitory neurotransmitters, especially in the insula. It also lists other proposed contributors: dysfunction of the stress-hormone (HPA) axis and the autonomic nervous system, low-grade inflammation, activation of glial cells (the nervous system’s support cells), and infections such as Epstein-Barr virus, Lyme disease and viral hepatitis. Twin studies point to a genetic component.
“Nociplastic pain”: the name for this kind of pain
Doctors now group fibromyalgia under nociplastic pain, meaning pain that arises from altered pain processing rather than from ongoing tissue damage or nerve injury. A 2020 review in Nature Reviews Rheumatology says fibromyalgia is the third most common musculoskeletal condition, affecting 2 to 3% of people worldwide, and that genetic predisposition, stressful life events and both peripheral and central mechanisms all feed into it. If you have been told your pain is real but “nothing shows up,” this is the explanation: the change is in how signals are processed, not in the joint or muscle that hurts.
If you want to understand how this fits with other long-term pain, our guide on chronic pain versus fibromyalgia walks through the differences.
What the research actually shows
If you have ever felt that people doubted your pain, the evidence in this section matters most. Researchers have measured the difference in several ways.
Pain thresholds. The Clauw paper reports that people with fibromyalgia feel pain at lower pressure levels than healthy controls in pressure-testing studies. Neuroimaging shows greater blood flow in pain-processing brain regions at lower pressures than in people without the condition. Their brains react more strongly to the same touch.
Brain scans. A review by Ceko, Bushnell and Gracely describes augmented sensory processing in pain-related brain areas, along with gray matter decreases and neurochemical abnormalities in areas that regulate pain.
Pain-signal amplification. A 2021 review describes an fMRI study of 37 people with fibromyalgia and 35 matched controls. Pain-signal amplification was around 50% higher in the fibromyalgia group. A combined four-stage fMRI analysis separated the two groups with 93% classification capacity, 92% sensitivity and 94% specificity. The same review notes that the brain signal increases were not linked to how long someone had the condition or to antidepressant use, which points to a stable biological pattern instead of something that simply builds with time.
These brain-imaging approaches are research tools. They show that the biology is real. They are not something you can book at a local clinic.
Why fatigue, poor sleep and brain fog come with the pain
Fibromyalgia is not only a pain condition, and the nervous system explains why. A review by Sluka and Clauw states that chronic overlapping pain conditions, such as irritable bowel syndrome, interstitial cystitis and jaw (temporomandibular) disorders, share similar underlying changes with fibromyalgia: altered central nervous system function that augments pain processing and also drives fatigue, sleep trouble, memory problems and mood difficulties. One underlying change, several symptoms.
Sleep that does not restore you
Sleep studies show real differences. A 2015 review of sleep in fibromyalgia reports that people with the condition have reduced slow-wave (deep) sleep and abnormal alpha rhythms, a pattern normally seen during wakefulness, appearing during non-REM sleep. The same paper notes that healthy people deprived of sleep can develop muscle aches, tenderness and fatigue, and that sleep loss weakens the descending pain-inhibition pathways. Poor sleep and amplified pain can feed each other.
A 2021 review confirms that sleep disorders confirmed by sleep studies are almost always present in fibromyalgia, including shorter sleep, more light sleep and more nighttime waking. So if you wake up tired no matter how many hours you spend in bed, that is a recognized feature of the condition, not a personal failing. If fatigue is your main complaint, this overview of chronic fatigue syndrome symptoms and solutions covers the overlap between the two conditions.
Fibro fog
Memory lapses, slowed thinking and trouble concentrating are common. Ceko and colleagues report that gray matter decreases in regions linked to emotional decision-making and working memory suggest “fibro fog” is tied to brain changes. Objective cognitive tests confirm deficits in processing speed, attention and memory even when depression is excluded. Our article on fibro fog goes deeper into what it feels like and why.
Beyond the brain: peripheral and autonomic nerves
Fibromyalgia is mostly thought of as centrally driven, but the picture is wider. The Merck Manual says it is mostly centrally mediated, while recent studies have implicated the peripheral nervous system through small fiber neuropathy, which is damage to the thinnest nerve fibers that sense pain and temperature.
A UK review of chronic pain and fatigue reports:
- Up to 60% of people with irritable bowel syndrome have fibromyalgia, and up to 70% of people with fibromyalgia have IBS symptoms.
- Autonomic nervous system problems, such as postural orthostatic tachycardia syndrome (PoTS, a racing heart on standing), are frequently found in fibromyalgia and ME/CFS.
- Small fiber neuropathy overlaps clinically with fibromyalgia, and the gold-standard diagnosis is a skin biopsy that measures nerve fiber density, performed only in specialist centers.
The autonomic nervous system controls things you do not think about: heart rate, digestion, temperature. That is why fibromyalgia can show up as dizziness, gut trouble or sensitivity to heat and cold, not only as aches.
Sluka and Clauw also describe a subset of people whose fibromyalgia occurs alongside conditions that cause ongoing pain input, such as autoimmune disorders or osteoarthritis. In that group, central nervous system changes appear to improve when the peripheral input is removed. If you have another painful condition, it is worth telling your doctor so both can be addressed. For readers exploring how nerve-related pain is approached in general, this page on nerve pain relief is one place to start.
What this means for getting a diagnosis
The nervous-system explanation raises a practical question: if the changes are real, why does diagnosis take so long?
For years, doctors relied on a tender-point exam. The American College of Rheumatology’s 2010 criteria dropped it in favor of two scales: a widespread pain index (WPI) that counts painful areas out of 19, and a symptom severity scale (SS) covering fatigue, unrefreshed waking, cognitive symptoms and other physical complaints. The case definition is WPI above 7 and SS above 5, or WPI of 3 to 6 and SS above 9. The paper reports that about 25% of people with fibromyalgia did not meet the older 1990 criteria, which is one reason the change was made.
A UK clinical review, written alongside Royal College of Physicians guidance, lists what doctors look for: widespread pain, intrusive fatigue, sensitivity to sound, light or temperature, symptoms lasting longer than three months, and past treatments that failed. It also notes that diagnosis can be delayed by years. The Clauw paper estimates that around 75% of people with the condition remain undiagnosed.
That delay is the frustration many patients describe: you are told your tests are normal, so you are left without a name for what is happening. If you are at this stage, these guides can help you prepare:
A worked example
Imagine someone with pain in her neck, hips and hands for eight months, who sleeps seven hours and wakes exhausted, and who loses words in the middle of sentences. Her X-rays and routine blood work are normal. A doctor using the 2010 criteria would count her painful areas on the WPI, score her fatigue, unrefreshing sleep and cognitive symptoms on the SS, and check whether the symptoms have lasted at least three months. She does not need to have a set number of tender points pressed. What she often lacks is something objective to hold up, to her family, her employer or an insurer. That is the gap we built our test to address.
How the FM1 Test fits in
The FM1® Test is a blood test that uses DNA science to identify immune-system changes related to fibromyalgia, chronic pain and fatigue. It identifies specific DNA genomic signatures in positive patients. It requires a quick blood draw at a local facility, results are available within about a week, and the test is Medicare- and insurance-covered. Positive respondents are offered access to a no-cost clinical trial. You can read the science behind it on our research page and find practical answers in the FM1 Test FAQ.
If your symptoms point to fibromyalgia and you want objective evidence to bring to your doctor, you can learn more and get started at fm1test.com.
Healthcare providers can use the same page to see how the test can support a clinical assessment alongside the standard criteria. If you are unsure where to start, our guide to the key diagnostic steps lays out the order of what to do.
Our perspective
The nervous-system research tells patients something we believe they deserve to hear plainly: your pain is not imaginary. Pain thresholds are lower, brain responses are stronger, and the chemistry of pain control is different. For people who have spent years being told otherwise, that matters.
What patients and doctors have lacked is something concrete to point to. A symptom questionnaire depends on how a person describes a bad week. We think fibromyalgia deserves the kind of evidence that other medical conditions get. That is why the FM1 Test looks for DNA genomic signatures that we have found in positive patients and that are not found in other disorders or in healthy people.
We also see the test as a doorway. It is Medicare- and insurance-covered, it needs only a blood draw, and results come back within about a week. For people who test positive, there is a no-cost clinical trial. A clear result can support a better conversation with a doctor, and that is the outcome we care about.
the author
FAQ
Is fibromyalgia a nervous system disease?
It is best described as a disorder of pain processing in the central nervous system. Researchers have found that both the pathways that send pain signals and the ones that suppress them work abnormally. Peripheral nerves and the autonomic nervous system may also be involved, and immune and other body systems are being studied.
Is fibromyalgia permanent?
The Merck Manual says fibromyalgia tends to be chronic, with symptoms persisting to some degree for most people. It also says the functional outlook is usually favorable with a comprehensive, supportive treatment program. Treating a coexisting mood disorder matters, because the outlook may be worse if one goes unaddressed.
Does fibromyalgia pain come from damaged muscles or joints?
No. The pain comes from amplified signal processing in the nervous system, not from ongoing tissue damage, which is why joint and muscle tests usually look normal. The 2020 Nature Reviews Rheumatology paper calls this nociplastic pain. Your pain is real even when imaging is clear.
Why am I so tired if I sleep all night?
Sleep studies show that people with fibromyalgia spend less time in deep sleep, and that wake-like brain rhythms intrude into sleep. You can spend a full night in bed and still wake unrefreshed. Tell your doctor about it, since unrefreshing sleep is also part of the diagnostic criteria.
How long does the FM1 Test take?
It needs a quick blood draw, and results are available within about a week. The FM1 Test FAQ covers insurance coverage and what to expect.
Sources
- The Science of Fibromyalgia, PMC (Clauw, Arnold, McCarberg, 2011)
- Fibromyalgia: an update on clinical characteristics, Nature Reviews Rheumatology (2020)
- Pain Mechanisms in Fibromyalgia: An Integrative Narrative Review, PMC (2026)
- Fibromyalgia: Diagnosis and Management, American Family Physician (2023)
- Neurobiology Underlying Fibromyalgia Symptoms, PMC (2011)
- Fibromyalgia and Associated Disorders: From Pain to Chronic Fatigue, PMC (2021)
- Neurobiology of fibromyalgia and chronic widespread pain, PMC (2016)
- The role of sleep in pain and fibromyalgia, PubMed (2015)
- Fibromyalgia, Merck Manual Professional Version (2026)
- The challenges of chronic pain and fatigue, PMC
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia (2010)
- The diagnosis of fibromyalgia syndrome, PMC (2022)